Moreover, we also found SENP6 deletions with a frequency of 29% (14/48) in a second DLBCL dataset (Supplementary Fig. 3b, TCGA DLBCL dataset), underscoring the relevance of the screening result for human lymphomas. Here, SENP6 is linked to diffuse large B-cell lymphoma.